These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation].
    Author: Chávez LL.
    Journal: Arch Cardiol Mex; 2007; 77 Suppl 2():S2-54-S2-58. PubMed ID: 17972380.
    Abstract:
    Multiple drugs are helpful for rate control in different tachyarrhythmias, in particular atrial fibrillation (AF). Betablockers (betaB) and calcium channel blockers have been used as monotherapy or as adjunctive therapy to antiarrhythmics for mantaining an acceptable ventricular rate. In recent years new concepts about auricular remodelation process as a consequence of AF has shown benefits with drugs as angiotensin-renin system blockers (ARSB) like angiotensin conversing enzime inhibitors (ACEI) and angiotensin receptor blockers (ARB). In this article it will be reviewed the benefits of rate control in AF by using betaB and calcium channel blockers and also the benefits in atrial remodelation process and the prevention of AF with ARSB drugs.
    [Abstract] [Full Text] [Related] [New Search]